Skip to main content
. 2017 Aug 7;12(8):e0182610. doi: 10.1371/journal.pone.0182610

Fig 3. Whole genome view of CNAs in an ovarian metastatic tumor sample and the newly established OVDM1 ovarian cancer cell line, derived from the same tumor.

Fig 3

(A) Whole genome CNA profiles of MT1 sample and OVDM1 cell line. (B) Frequency of CNAs considering MT1 and early, middle and late passages of OVDM1. Blue lines–gains, red–losses.